NEX-I, Inc.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Request demo

NEX-I, Inc. - overview

About

Founded in 2021 and based in Seoul, South Korea, NEX-I, Inc. , dba NEX-I, is a bio venture and next-generation immunotherapy drug development company that specializes in immuno-cancer drugs that increase the response rate by discovering refractory inducing factors. The company is conducting research on drug administration to cancer patients who do not respond to immunotherapy with the goal to overcome the limitation of the low response rate of existing immunotherapy. In October 2022, NEX-I, Inc.

raised KRW 22 billion in series A funding from new investors CJ ENM, Green Cross Holdings, Medytox Venture Investment, Stonebridge Ventures, T. S. Investment, and WONIK Investment Partners. Returning investors Atinum Investment, DSC Investment, Hana Ventures, and Schmidt also participated in this round.

NEX-I, Inc. offers immuno-cancer drugs. The company will use the October funding to continue R&D in its systems.

Current Investors

Schmidt, Korea Tech Incubator for Startup, DSC Investment

Request a demo

Primary Industry

Healthcare Specialists

Sub Industries

Oncology/Cancer Treatment, Pharmaceutical Research & Development, Specialty Pharmaceuticals

Website

www.nex-i.co.kr

Verticals

HealthTech, Manufacturing

Company Stage

Series B

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.

Request demo